Description:
GLP-2 (TZ) — Dual Incretin Agonist Research Peptide (GLP-1 / GIP)
GLP-2 (TZ) is a synthetic peptide analog developed for laboratory research examining dual incretin receptor signaling through the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) pathways. It is supplied exclusively for non-clinical investigation into integrated metabolic and endocrine signaling mechanisms.
Research areas of interest include:
- Dual-receptor pathway modeling, focusing on GLP-1R and GIPR signaling synergy
- Metabolic research models evaluating glucose regulation and energy balance pathways
- Incretin-mediated endocrine signaling and pathway cross-talk studies
- Exploratory combination research strategies involving incretin-pathway agents
This peptide is commonly utilized in advanced metabolic research exploring multi-pathway incretin signaling and coordinated endocrine regulation within controlled laboratory settings.
Intended Use:
For laboratory research use only. Not for human or veterinary use.

